Skip to main content
logo
Applied Therapeutics, Inc. (APLT)
Feb 3, 2026 - APLT was delisted (reason: acquired by Cycle Pharmaceuticals)
0.1030
0.00 (0.00%)
Inactive · Last trade price on Feb 2, 2026

Applied Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
10.469.99---
Revenue Growth
--95.45%----
Gross Profit
-38.06-48.29-43.91-55.63--
Operating Income
-99.61-104.3-64.54-82.95-105.62-94.47
Net Income
-18.14-105.62-119.76-82.51-105.58-93.96
Earnings Per Share
-0.13-0.76-1.42-2.18-4.12-4.28
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Investments
11.9579.449.930.5880.8296.83
Total Debt
2.52.80.781.512.122.81
Net Cash (Debt)
9.4576.649.1229.0778.794.02
Net Cash Growth
-90.25%55.95%68.99%-63.07%-16.29%155.38%
Net Cash Per Share
0.070.550.580.773.074.28

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Cash Flow
-86.85-84.31-55.17-78.09-90.73-78.21
Free Cash Flow
-86.85-84.31-55.17-78.09-90.73-78.21
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Margin
-9961.20%-22922.86%-645.80%---
Pretax Margin
-1813.80%-23214.07%-1198.47%---
Profit Margin
-1813.80%-23214.07%-1198.47%---

Valuation
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingAug '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
14.93218.9625.89---